Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
Eleanor Drummond, Tomas Kavanagh, Geoffrey Pires, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Compilation of reported protein changes in the brain in Alzheimer’s disease
Manor Askenazi, Tomas Kavanagh, Geoffrey Pires, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 75
Cryo-EM structures of amyloid-β and tau filaments in Down syndrome
Anllely Fernández, Md Rejaul Hoq, Grace I. Hallinan, et al.
Nature Structural & Molecular Biology (2024) Vol. 31, Iss. 6, pp. 903-909
Open Access | Times Cited: 16
Proteomic changes in Alzheimer disease associated with progressive Aβ plaque and tau tangle pathologies
Alexa Pichet Binette, Chris Gaiteri, Malin Wennström, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 10, pp. 1880-1891
Open Access | Times Cited: 16
Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer’s disease, and late-onset Alzheimer’s disease
Mitchell Martà-Ariza, Dominique Leitner, Evgeny Kanshin, et al.
Acta Neuropathologica (2025) Vol. 149, Iss. 1
Open Access | Times Cited: 2
CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease
Emma L. van der Ende, Sjors G. J. G. In ‘t Veld, Iris Hanskamp, et al.
Brain (2023) Vol. 146, Iss. 11, pp. 4495-4507
Open Access | Times Cited: 29
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias
Charlotte E. Teunissen, Leighann Kimble, Sherif Bayoumy, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 10, pp. 100629-100629
Open Access | Times Cited: 22
Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches
Amirreza Gholami
Neuroscience Letters (2023) Vol. 817, pp. 137532-137532
Closed Access | Times Cited: 22
Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid
Aleksandra Wojtas, Eric B. Dammer, Qi Guo, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 6, pp. 4043-4065
Open Access | Times Cited: 11
Alterations in Alzheimer's disease microglia transcriptome might be involved in bone pathophysiology
Mohini Gharpure, Sagar Vyavahare, Pankaj Ahluwalia, et al.
Neurobiology of Disease (2024) Vol. 191, pp. 106404-106404
Open Access | Times Cited: 10
Human brain glycoform coregulation network and glycan modification alterations in Alzheimer’s disease
Qi Zhang, Cheng Ma, Lih‐Shen Chin, et al.
Science Advances (2024) Vol. 10, Iss. 14
Open Access | Times Cited: 10
Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer’s disease
Yona Levites, Eric B. Dammer, Yong Ran, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101669-101669
Open Access | Times Cited: 10
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Elisabet A. Frick, Valur Emilsson, Þórarinn Jónmundsson, et al.
Nature Aging (2024) Vol. 4, Iss. 10, pp. 1446-1464
Open Access | Times Cited: 9
CSF proteomics identifies early changes in autosomal dominant Alzheimer’s disease
Yuanyuan Shen, Jigyasha Timsina, Gyujin Heo, et al.
Cell (2024) Vol. 187, Iss. 22, pp. 6309-6326.e15
Open Access | Times Cited: 8
Glymphatic system clearance and Alzheimer’s disease risk: a CSF proteome-wide study
Natàlia Cullell, Giovanni Caruana, Andrea Elias-Mas, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Human and mouse proteomics reveals the shared pathways in Alzheimer’s disease and delayed protein turnover in the amyloidome
Jay M. Yarbro, Xian Han, Abhijit Dasgupta, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach
Xavier Morató, Vanesa Pytel, Sara Jofresa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9305-9305
Open Access | Times Cited: 32
A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer’s disease
Annett Boeddrich, Christian Haenig, Nancy Neuendorf, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Proteomics analysis of prefrontal cortex of Alzheimer’s disease patients revealed dysregulated proteins in the disease and novel proteins associated with amyloid-β pathology
Ana Montero‐Calle, Raquel Coronel, María Garranzo‐Asensio, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 6
Closed Access | Times Cited: 16
Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer’s disease
Gabriele Vilkaite, Jacob W. Vogel, Niklas Mattsson
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101735-101735
Open Access | Times Cited: 7
Large‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity
Fatemeh Seifar, Edward J. Fox, Anantharaman Shantaraman, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 7
Systematic proteomics in Autosomal dominant Alzheimer’s disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathways
Yuanyuan Shen, Muhammad Ali, Jigyasha Timsina, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
The influence of APOEε4 on the pTau interactome in sporadic Alzheimer’s disease
Manon Thierry, Jackeline Ponce, Mitchell Martà-Ariza, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 6
Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies
Jie Miao, Yanli Zhang, Su Chen, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 6
Are fibrinaloid microclots a cause of autoimmunity in Long Covid and other post-infection diseases?
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2023) Vol. 480, Iss. 15, pp. 1217-1240
Open Access | Times Cited: 15
Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer’s disease brain proteomic signature
Jackson A. Roberts, Vijay R. Varma, Julián Candia, et al.
npj Aging (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top